Abel L. Robertson

2.7k citations
52 papers · 2.1k indexed · 1 hit paper · h-index 23
Topics
Atherosclerosis and Cardiovascular Diseases (8 papers)Peroxisome Proliferator-Activated Receptors (6 papers)Fatty Acid Research and Health (5 papers)

In The Last Decade

Abel L. Robertson

52 papers receiving 1.9k citations

Hit Papers

LDL-induced cytotoxicity and its inhibition by HDL in hum...19792026199420101979100200300400

Peers

Abel L. Robertson
Comparison fields: 5 of 123
  • Molecular Biology 594
  • Cardiology and Cardiovascular Medicine 529
  • Surgery 409
  • Immunology 332
  • Endocrinology, Diabetes and Metabolism 300
Replace Toshiyuki Kita with:
Toshiyuki Kita Japan
T B Rajavashisth United States
Fahumiya Samad United States
C. Michael Hart United States
Wee Soo Shin Japan
Martin McBride United Kingdom
Iván P. Uray United States
Dongqi Xing United States
Hiroshi Ishizaka Japan
Daniel Petrovič Slovenia
Abel L. Robertson relative to Toshiyuki Kita Japan Toshiyuki Kita's profile →
Citations per field
00.5×2.5×
Toshiyuki Kita · 1×
Citations per year

Countries citing papers authored by Abel L. Robertson

Since Specialization
Citations

This map shows the geographic impact of Abel L. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel L. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel L. Robertson more than expected).

Fields of papers citing papers by Abel L. Robertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abel L. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel L. Robertson. The network helps show where Abel L. Robertson may publish in the future.

Co-authorship network of co-authors of Abel L. Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Abel L. Robertson. A scholar is included among the top collaborators of Abel L. Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abel L. Robertson. Abel L. Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 34
2 18
3 17
4 22
5 4
6 13
7 1
8 50
9 3
10 8
11 23
12 43
13 29
14
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culturebreakdown →
426
15 7
16 42
17 1
18 2
19 6
20 25

About Abel L. Robertson

Abel L. Robertson is a scholar working on Hematology, Immunology and Immunology and Allergy, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Fatty Acid Research and Health (5 papers). The work is most often cited by research in Biochemistry (231 citations), Cardiology and Cardiovascular Medicine (529 citations) and Endocrinology, Diabetes and Metabolism (300 citations). Abel L. Robertson has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Philip A. Khairallah, Guy Chisolm, Guðmundur Þorgeirsson, Nicholas P. Ziats, Antanas Butkus, Lena A. Lewis, John C.M. Tsibris, Mahmoud Y. El‐Najjar, Stephen Bottomley and L. Allen Ehrhart. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026